We are proud to share these recent relevant publications by the teams involved in MyPeBS consortium Manchester team highlighted for the first time, the ability of a risk model (Tyrer Cuzick) including density and SNPs not only to predict for breast cancer risk, but...

A woman’s risk of breast cancer is affected by her genetic make up.  Some bits of the normal genetic material (DNA) differs between one person and another: they are known as single nucleotide polymorphisms or SNPs.  Different combinations of these SNPs are associated...

Almost 100 partners as well as stakeholders of the project met in Paris on September 28th 2018 to prepare the launch of the MyPeBS clinical trial. It was the opportunity for all participants to get practical information on all operational aspects of the clinical...

All partners got together in Paris, on January 12th2018 for the first consortium meeting, to launch the MyPeBS project. Organizational and conceptual issues were discussed regarding the project and the clinical trial. This meeting also was the opportunity for many of...